Cite
Cha RH, Kang SW, Park CW, et al. Sustained uremic toxin control improves renal and cardiovascular outcomes in patients with advanced renal dysfunction: . Kidney Res Clin Pract. 2017;36(1):68-78doi: 10.23876/j.krcp.2017.36.1.68.
Cha, R. H., Kang, S. W., Park, C. W., Cha, D. R., Na, K. Y., Kim, S. G., Yoon, S. A., Kim, S., Han, S. Y., Park, J. H., Chang, J. H., Lim, C. S., & Kim, Y. S. (2017). Sustained uremic toxin control improves renal and cardiovascular outcomes in patients with advanced renal dysfunction: . Kidney research and clinical practice, 36(1), 68-78. https://doi.org/10.23876/j.krcp.2017.36.1.68
Cha, Ran-Hui, et al. "Sustained uremic toxin control improves renal and cardiovascular outcomes in patients with advanced renal dysfunction: ." Kidney research and clinical practice vol. 36,1 (2017): 68-78. doi: https://doi.org/10.23876/j.krcp.2017.36.1.68
Cha RH, Kang SW, Park CW, Cha DR, Na KY, Kim SG, Yoon SA, Kim S, Han SY, Park JH, Chang JH, Lim CS, Kim YS. Sustained uremic toxin control improves renal and cardiovascular outcomes in patients with advanced renal dysfunction: . Kidney Res Clin Pract. 2017 Mar;36(1):68-78. doi: 10.23876/j.krcp.2017.36.1.68. Epub 2017 Mar 31. PMID: 28392999; PMCID: PMC5331977.
Copy
Download .nbib